Panic Disorder Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 1stDecember 2014

Summary
The industry analysis specialist, has released its new report, Panic Disorder Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Panic Disorder Therapeutics market. The report
identifies the key trends shaping and driving the global Panic Disorder Therapeutics market. The
report also provides insights on the prevalent competitive landscape and the emerging players
expected to significantly alter the market positioning of the current market leaders. Most
importantly, the report provides valuable insights on the pipeline products within the global
Panic Disorder Therapeutics sector. This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house analysis by GlobalDatas
team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-panic-disorder-therapeutics-pipeline-assessment-and-marketforecasts-135217

Scope
The report provides information on the key drivers and challenges of the Panic Disorder
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Panic
Disorder Therapeutics market revenues data from 2006 to 2011, forecast for eight years to
2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Panic Disorder
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Panic Disorder Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Panic Disorder Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Panic
Disorder Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Panic Disorder Therapeutics market
in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

partnerships.
- Whats the next big thing in the global Panic Disorder Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Panic Disorder Therapeutics - Introduction
2.1 Disease Overview
2.1.1 Panic Disorder
2.1.2 Panic Attack
2.1.3 Difference between Panic Attacks and Panic Disorder
2.2 Epidemiology
2.2.1 Prevalence
2.2.2 Gender
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.2.3 Economic Burden

2.2.4 Quality of Life Parameters
2.3 Pathophysiology
2.3.1 Neurochemical Involvement
2.3.2 Etiology
2.3.3 Genetic and Biologic Theories
2.3.4 Psychological Theories
2.4 Signs and Symptoms
2.5 Diagnosis
2.5.1 Comorbidity
2.5.2 Rating Scales
2.6 Treatment and Management Pattern
2.6.1 Psychological treatment
2.6.2 Pharmacological Treatment
2.7 Referral Pathway
2.8 GlobalData Pipeline Report Guidance
3 Panic Disorder Therapeutics - Market Characterization
3.1 Overview
3.2 Panic Disorder Therapeutics Market Size (2006-2011) - Global
3.3 Panic Disorder Therapeutics Market Forecast (2011-2019) - Global
3.4 Panic Disorder Therapeutics Market Size (2006-2011) - the US
3.5 Panic Disorder Therapeutics Market Forecast (2011-2019) - the US
3.6 Panic Disorder Therapeutics Market Size (2006-2011) - France
3.7 Panic Disorder Therapeutics Market Forecast (2011-2019) - France
3.8 Panic Disorder Therapeutics Market Size (2006-2011) - Germany
3.9 Panic Disorder Therapeutics Market Forecast (2011-2019) - Germany
3.10 Panic Disorder Therapeutics Market Size (2006-2011) - Italy
3.11 Panic Disorder Therapeutics Market Forecast (2011-2019) - Italy
3.12 Panic Disorder Therapeutics Market Size (2006-2011) - Spain
3.13 Panic Disorder Therapeutics Market Forecast (2011-2019) - Spain
3.14 Panic Disorder Therapeutics Market Size (2006-2011) - the UK
3.15 Panic Disorder Therapeutics Market Forecast (2011-2019) - the UK
3.16 Panic Disorder Therapeutics Market Size (2006-2011) - Japan
3.17 Panic Disorder Therapeutics Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers for the Panic Disorder Therapeutics Market
3.18.1 Drivers for the Panic Disorder Therapeutics Market
3.18.2 Barriers for the Panic Disorder Therapeutics Market
3.19 Opportunity and Unmet Need Analysis
3.20 Key Takeaway
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4 Panic Disorder Therapeutics - Competitive Assessment

4.1 Overview
4.1.1 Strategic Competitor Assessment
4.2 Product Profiles, Major Marketed Products in the Panic Disorder Therapeutics Market
4.2.1 Selective Serotonin Reuptake Inhibitors
4.2.2 Serotonin-Nonadrenaline Reuptake Inhibitors
4.2.3 Benzodiazepines
4.2.4 Tricyclic Antidepressants
4.3 Key Takeaway
5 Panic Disorder Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Panic Disorder Therapeutics Pipeline - Pipeline by Phases of Development
5.3.1 Panic Disorder Therapeutics - Phase II Pipeline
5.4 Panic Disorder Therapeutics Market - Clinical Pipeline by Mechanism of Action
5.5 Technology Trends Analytic Framework
5.6 Panic Disorder Therapeutics - Promising Drugs under Clinical Development
5.7 Molecule Profile for Promising Drugs under Clinical Development
5.7.1 AZ-002 (Staccato alprazolam)
5.7.2 ABIO-08/01
5.8 Key Takeaway
6 Panic Disorder Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Top Companies Participating in Panic Disorder Therapeutics Clinical Trials
7 Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Panic Disorder Therapeutics - Implications for Future Market Competition
8 Panic Disorder Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Alexza Pharmaceuticals
8.2.2 BTG International (BTG)
9 Licensing and Partnership Deals
10 Panic Disorder Therapeutics - Appendix
10.1 Market Definitions
10.2 Abbreviations
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: Comparison of Germany with Estimates of Costs from the US (PPP, 2010)
Table 2: Cost Per Person with Panic Disorder
Table 3: Recommended Starting And Therapeutic Doses of SSRIs for Panic Disorder
Table 4: Panic Disorder Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 5: Panic Disorder Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 6: Panic Disorder Therapeutics Market, the US, Revenue ($m), 2006-2011
Table 7: Panic Disorder Therapeutics Market, the US, Forecast ($m), 2011-2019
Table 8: Panic Disorder Therapeutics Market, France, Revenue ($m), 2006-2011
Table 9: Panic Disorder Therapeutics Market, France, Forecast ($m), 2011-2019
Table 10: Panic Disorder Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 11: Panic Disorder Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 12: Panic Disorder Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 13: Panic Disorder Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 14: Panic Disorder Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 15: Panic Disorder Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 16: Panic Disorder Therapeutics Market, the UK, Revenue ($m), 2006-2011
Table 17: Panic Disorder Therapeutics Market, the UK, Forecast ($m), 2011-2019
Table 18: Panic Disorder Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 19: Panic Disorder Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 20: SSRIs Approved for Panic Disorder
Table 21: Adverse Events Incidence in Panic Disorder Placebo-Controlled Clinical Trials
Table 22: Adverse Events Incidence in Placebo Controlled Clinical Trials
Table 23: Adverse Events in Placebo Controlled Clinical Trials for Panic Disorder
Table 24: Adverse Events in Short Term Placebo Controlled Effexor XR Clinical Trials in Panic
Disorder Patients
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 25: Benzodiazepines Approved for Panic Disorder

Table 26: Panic Disorder Therapeutics, Phase II Pipeline, 2011
Table 27: Panic Disorder Therapeutics - Most Promising Drugs under Clinical Development,
2011
Table 28: Panic Disorder Therapeutics, Clinical Trials by Country, 2011
Table 29: Panic Disorder Therapeutics, Clinical Trials by Phase, 2011
Table 30: Panic Disorder Therapeutics, Clinical Trials by Status of Development, 2011
Table 31: Panic Disorder Therapeutics, Prominent Sponsors, 2011
Table 32: Panic Disorder Therapeutics, Top Companies Participating in Therapeutics Clinical
Trials, 2011
Table 33: Alexza Pharmaceuticals - Neuroscience Pipeline, 2011
Table 34: Alexza Pharmaceuticals - Panic Disorder Pipeline, 2011
Table 35: BTG - Neuroscience Therapeutics Pipeline Products, 2011
Table 36: BTG - Panic Disorder Therapeutics Pipeline Products, 2011
Table 37: Panic Disorder Therapeutics, Global, Deals, 2009-2011

List Of Figures
Figure 1: Type of Anxiety Disorders
Figure 2: Panic Attack : Cognitive Behavioral Therapy Model
Figure 3: Life Time and 12 Month Prevalence of Panic Disorder, the US
Figure 4: Unchecked Panic: A "Triple A" Threat
Figure 5: Symptoms of Panic Disorder
Figure 6: Difference between the Diagnostic Criteria for Panic Disorder by ICD-10 and DSM-IV
Figure 7: Diagnostic Criteria for Panic Disorder Without Agoraphobia
Figure 8: Comorbidity Associated with Panic Disorder
Figure 9: Panic Disorder Treatment Options
Figure 10: Referral Pathway for Panic Disorder
Figure 11: Panic Disorder Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 12: Panic Disorder Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 13: Panic Disorder Therapeutics Market, the US, Revenue ($m), 2006-2011
Figure 14: Panic Disorder Therapeutics Market, the US, Forecast ($m), 2011-2019
Figure 15: Panic Disorder Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 16: Panic Disorder Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 17: Panic Disorder Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 18: Panic Disorder Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 19: Panic Disorder Therapeutics Market, Italy, Revenue ($m), 2006-2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 20: Panic Disorder Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 21: Panic Disorder Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 22: Panic Disorder Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 23: Panic Disorder Therapeutics Market, the UK, Revenue ($m), 2006-2011
Figure 24: Panic Disorder Therapeutics Market, the UK, Forecast ($m), 2011-2019
Figure 25: Panic Disorder Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 26: Panic Disorder Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 27: Opportunity and Unmet Need in the Panic Disorder Therapeutics Market for SSRIs
and Benzodiazepines, 2011
Figure 28: Panic Disorder Therapeutics, Strategic Competitor Assessment, 2011
Figure 29: Panic Disorder Therapeutics, Technology Trends Analytics Framework, 2011
Figure 30: Panic Disorder Therapeutics, Technology Trends Analytics Framework, Description,
2011
Figure 31: Panic Disorder Therapeutics, Clinical Trials by Country, 2011
Figure 32: Panic Disorder Therapeutics, Clinical Trials by Phase (%), 2011
Figure 33: Panic Disorder Therapeutics, Clinical Trials by Status of Development (%), 2011
Figure 34: Panic Disorder Therapeutics, Overall Sponsors (%), 2011
Figure 35: Panic Disorder Therapeutics, Prominent Sponsors (%), 2011
Figure 36: Panic Disorder Therapeutics, Top Companies Participating in Clinical Trials, 2011
Figure 37: Panic Disorder Therapeutics Market, Drivers and Restraints, 2011
Figure 38: Implications for Future Market Competition in the Panic Disorder Market, 2011
Figure 39: Panic Disorder Therapeutics Market, Pipeline by Company, 2011
Figure 40: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Related Reports:
Amyloidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Cushings Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Laryngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chemotherapy-Induced Nausea and Vomiting (CINV) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Melanoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Liposarcoma Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Nasopharyngeal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Anal Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

To know more on Panic Disorder Therapeutics - Pipeline Assessment and Market

Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-panic-disordertherapeutics-pipeline-assessment-and-market-forecasts-135217

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/